Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Down 6.6% – Here’s What Happened

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) fell 6.6% during mid-day trading on Friday . The company traded as low as $15.37 and last traded at $15.37. 2,797 shares were traded during mid-day trading, a decline of 83% from the average session volume of 16,252 shares. The stock had previously closed at $16.46.

Analyst Upgrades and Downgrades

TLX has been the subject of several research reports. William Blair upgraded shares of Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a report on Tuesday, November 19th. UBS Group began coverage on shares of Telix Pharmaceuticals Limited American Depositary Shares in a research note on Friday, November 15th. They set a “buy” rating and a $21.00 target price for the company.

Telix Pharmaceuticals Limited American Depositary Shares Stock Performance

About Telix Pharmaceuticals Limited American Depositary Shares

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.